Puerarin Mitigates Diabetic Hepatic Steatosis and Fibrosis by Inhibiting TGF-β Signaling Pathway Activation in Type 2 Diabetic Rats

Lipid metabolism disorder and inflammation are essential promoters in pathogenesis of liver injury in type 2 diabetes. Puerarin (PUR) has been reported to exert beneficial effects on many diabetic cardiovascular diseases and chemical-induced liver injuries, but its effects on diabetic liver injury a...

Descripción completa

Detalles Bibliográficos
Autores principales: Hou, Biyu, Zhao, Yuerong, Qiang, Guifen, Yang, Xiuying, Xu, Chunyang, Chen, Xi, Liu, Chenge, Wang, Xiaobo, Zhang, Li, Du, Guanhua
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi 2018
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6051041/
https://www.ncbi.nlm.nih.gov/pubmed/30057680
http://dx.doi.org/10.1155/2018/4545321

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6051041/
https://www.ncbi.nlm.nih.gov/pubmed/30057680
http://dx.doi.org/10.1155/2018/4545321

Ejemplares similares